Reliv International

RELV · OTC

$1.65−$0.01 (−0.60%)TodayMarket closed ·
No price history for this range.

About RELV

Reliv International, Inc. engages in the development, manufacture, and marketing of a proprietary line of nutritional supplements. The company sells its products through an international network marketing system using independent distributors. The company operates through network marketing segment consisting of six operating units that sell nutritional and dietary products to a sales force of independent distributors that sell the products directly to customers. Its products include Reliv Now with Soy; FibRestore; Innergize! Go; LunaRich; ReversAge; Reliv Now for Kids; Arthaffect; ProVantage; SoySentials; CardioSentials; RLV Hemp Balm; Reliv Now with Whey, and others. Its international markets include Australia, New Zealand, Canada, Malaysia, Mexico, the Philippines, the United Kingdom, Ireland, France, Germany, Austria and the Netherlands. Its subsidiaries include Reliv, Inc., Reliv World Corporation, Reliv Australia Pty, and others.

Employees
0
Headquarters
Chesterfield Missouri, Missouri
Listed
Mar 8, 1993
Sector
Consumer Staples
Industry
Personal Care Products
Website
reliv.com

RELV key statistics

Market cap
2.88M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
2.69K
Volume
6
Open price
$1.54
High today
$1.65
Low today
$1.46
52 Week high
$3.50
52 Week low
$1.70

Reliv International (RELV) at a glance

Reliv International (RELV) last traded at $1.65, with a market cap of 2.88M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $1.46 and $1.65. The current price is 13.0% above the day's low and 0.0% below its high.

Volume so far is 6 shares, below the average of 2.69K shares a day.

Over the past year Reliv International has ranged from $1.70 to $3.50, and now sits -3% of the way up that range.

Reliv International met or beat analyst EPS estimates in 2 of the last 8 quarters. In Q2 FY10 it reported $0.14 per share against an estimate of $0.2142.

RELV earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 2 of the last 8 quarters, by 71.6% on average.

  1. Q3 FY08: reported $0.28 per share against an estimate of $0.2856
  2. Q4 FY08: reported $0.42 per share against an estimate of $0.2856
  3. Q1 FY09: reported $0.49 per share against an estimate of $0.6426
  4. Q2 FY09: reported $0.21 per share against an estimate of $0.2142
  5. Q3 FY09: reported $0.21 per share against an estimate of $0.2856
  6. Q4 FY09: reported $0.42 per share against an estimate of $0.2142
  7. Q1 FY10: reported $0.42 per share against an estimate of $0.4284
  8. Q2 FY10: reported $0.14 per share against an estimate of $0.2142

Similar companies

Companies in the same industry as Reliv International

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.